NCT02608255

A Prospective Pilot Study to Evaluate a New Marker of Ischemia in Chest Pain Triage

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: Assistance Publique Hopitaux De Marseille · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

A Single-center prospective pilot study enrolling chest pain patients. CD 26 measurement will be performed and compared to troponin µs for early triage of these patients. This novel biomarker of myocardial ischemia (CD26) will be measured at the time of first medical contact (T0) and after 30 min simultaneously o troponin Ic. All patients aged over 18 years with chest pain which may be related to acute coronary syndrome requiring pre hospital medical contact through the Emergency Medical Service.

Detailed description

First objectives: demonstrating the early positivity of CD26 compared to ultra-sensitive troponin.

Conditions

• Acute Coronary Syndrome

Interventions

Type	Name	Description
OTHER	blood samples

Timeline

• Start date: 2016-01-01
• Primary completion: 2016-11-01
• Completion: 2017-01-01
• First posted: 2015-11-18
• Last updated: 2017-01-04

Locations

1 site across 1 country: France